STREPTOMYCIN TOXICITY
- 21 June 1947
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 134 (8), 679-688
- https://doi.org/10.1001/jama.1947.02880250027007
Abstract
It is probable that the principal value of streptomycin will be in the treatment of subacute and chronic infections, notably tuberculosis, in which it will be necessary to administer the drug for long periods. Evaluation of the chronic toxicity of the material for human beings is thus appreciably more important than is the case with sulfonamide compounds or penicillin. The effects of the short term administration of preparations of impure streptomycin to human subjects have been studied both by a number of independent investigators and in a cooperative study under the auspices of the National Research Council.1 The only observations on long-continued administration of impure streptomycin are those presented in a preliminary report by Hinshaw and Feldman.2 In their study an average daily dose of 1.5 Gm. of the drug was administered for periods of several or more months. In all the reports there is agreement that inKeywords
This publication has 6 references indexed in Scilit:
- ABSORPTION, DISTRIBUTION AND EXCRETION OF STREPTOMYCINArchives of Internal Medicine, 1946
- SOME TOXICOLOGICAL AND PHARMACOLOGICAL PROPERTIES OF STREPTOMYCIN1946
- THE ABSORPTION, DISTRIBUTION, AND EXCRETION OF STREPTOMYCIN IN MAN 1Journal of Clinical Investigation, 1946
- THE ABSORPTION AND EXCRETION OF STREPTOMYCIN IN HUMAN CHRONIC TYPHOID CARRIERSJournal of Clinical Investigation, 1945
- The Absorption, Excretion and Toxicity of Streptomycin in ManNew England Journal of Medicine, 1945
- A RAPID METHOD FOR THE SEPARATION OF SERUM ALBUMIN AND GLOBULINPublished by Elsevier ,1940